ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Treating Post Traumatic Stress Disorder in Children Exposed to Domestic Violence

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Treating Post Traumatic Stress Disorder in Children Exposed to Domestic Violence
Official Title  Treating PTSD in Children Exposed to Domestic Violence
Brief Summary

This study will determine whether trauma-focused cognitive behavioral therapy (TF-CBT) is more effective than child-centered therapy (CCT) in reducing post traumatic stress disorder (PTSD) in children exposed to domestic violence (DV).

Detailed Description

Up to 10 million children in the United States are exposed to DV directed at their mothers by intimate partners. DV exposure puts these children at an increased risk for developing behavioral problems, depression, anxiety, and PTSD. While studies targeting PTSD in DV-exposed children are limited, data indicates that TF-CBT is effective in improving PTSD as well as depression, anxiety, and behavioral symptoms. This study will determine the effectiveness of TF-CBT in reducing PTSD and other DV-related psychological symptoms in children from a community DV agency in Pittsburgh, Pennsylvania.

This study will last 8 weeks. Children and their mothers will be randomly assigned to receive 8 weeks of either TF-CBT or CCT. In TF-CBT, patients recall the events of their trauma and try to deal with the emotions that arise. Supportive treatment empowers children to deal with their emotions in general. Both the children and their mothers will complete questionnaires at study entry and at Week 8. Children will also complete self-report scales at study entry and at Week 8. The questionnaires and self-report scales will be used to assess symptoms of PTSD, depression, anxiety, and behavioral problems. Children and their mothers will be contacted 6 and 12 months after study completion for follow-up interviews.

Study Phase
Study Type  Interventional
Study Design  Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Primary Outcome Measure  PTSD symptoms [ Time Frame: Measured before and after treatment and Months 6 and 12 of follow-up ] [ Designated as safety issue: No ]
Anxiety [ Time Frame: Measured before and after treatment and Months 6 and 12 of follow-up ] [ Designated as safety issue: No ]
Depression [ Time Frame: Measured before and after treatment and Months 6 and 12 of follow-up ] [ Designated as safety issue: No ]
Behavior [ Time Frame: Measured before and after treatment and Months 6 and 12 of follow-up ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Contact with perpetrator [ Time Frame: Measured at every treatment session ] [ Designated as safety issue: Yes ]
Condition  Stress Disorders, Post-Traumatic
Anxiety
Depression
Intervention  Behavioral: Trauma-focused cognitive behavioral therapy (TF-CBT)
Behavioral: Child-centered supportive therapy (CCT)
MEDLINE PMIDs
Links Click here to learn more about the National Child Traumatic Stress Network This link exits the ClinicalTrials.gov site
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  80
Start Date  May 2004
Completion Date May 2009
Eligibility Criteria 

Inclusion Criteria:

  • Diagnosis of PTSD related to exposure to DV, defined as their mother having been the victim of intimate partner violence within 1 year prior to study entry
  • Able to read and understand English
  • Parent or guardian able to read and understand English
  • Parent or guardian willing to give informed consent

Exclusion Criteria:

  • Certain psychiatric disorders which preclude participation in cognitive-based treatment
Gender Both
Ages 7 Years to 14 Years
Accepts Healthy Volunteers No
Contacts ††
Contact: Judith A. Cohen, MD     412-330-4312     jcohen1@wpahs.org    
Contact: Anthony P. Mannarino, PhD     412-330-4312     amannari@wpahs.org    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00183326
Organization ID R01 MH72590
Secondary IDs †† DDTR B3-PDS
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Judith A. Cohen, MD     Allegheny Singer Research Institute    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date February 2008
First Received Date  September 12, 2005
Last Updated Date February 12, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers